Effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of dizziness caused by cerebral arteriosclerosis: a multi-center, double-blind, randomized controlled trial.

Saved in:
Bibliographic Details
Title: Effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of dizziness caused by cerebral arteriosclerosis: a multi-center, double-blind, randomized controlled trial.
Authors: Sha RN; the First clinical medical college, Beijing University of Chinese Medicine, Beijing 100029, China., Tang L; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China., Du YW; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China., Wu SX; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China., Shi HW; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China., Zou HX; the First clinical medical college, Beijing University of Chinese Medicine, Beijing 100029, China., Zhang XR; the First clinical medical college, Beijing University of Chinese Medicine, Beijing 100029, China., Dong XL; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China., Zhou L; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Source: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan [J Tradit Chin Med] 2022 Feb; Vol. 42 (1), pp. 83-89.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Academy Of Traditional Chinese Medicine Country of Publication: China NLM ID: 8211546 Publication Model: Print Cited Medium: Internet ISSN: 2589-451X (Electronic) Linking ISSN: 02552922 NLM ISO Abbreviation: J Tradit Chin Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first